News › Clinical Practice, Industry News, Patient Care

More new therapies under study for underarm sweat

November 13, 2018

The approval of the topical glycopyrronium tosylate (Qbrexza, Dermira) for primary axillary hyperhidrosis may soon be followed by other treatments for the condition, says David M. Pariser, M.D., FAAD, in a presentation made at the Fall Clinical Dermatology Conference taking place this week in Las Vegas.
“It’s really exciting that there is something new after a period of 12 years or so of drought in innovation,” said Dr. Pariser, of the Eastern Virginia Medical School in Norfolk, Va. “Not only is there something new, but there are several new things in the pipeline for patients.”
Read more at Dermatology Times >>

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • Allergan Aesthetics Receives Approval for Boey® (trenibotulinumtoxinE) in Canada
    • SafeLink Consulting Becomes Platinum Vendor Affiliate with the American Med Spa Association
    • Allergan Aesthetics’ Skinvive by Juvéderm Receives FDA Approval for the Improvement of Neck Appearance
    • Obagi Medical Announces FDA Approval of Obagi saypha ChIQ Injectable Hyaluronic Acid Gel
    • MedSafe Becomes Gold Vendor Affiliate with the American Med Spa Association